Clinical Trial Update: Locally Advanced NSCLC Treated With Radiochemotherapy: Phase 2 Study on the Value of a Stereotactic Boost [Phase 2]

View source ↗

Summary

A Phase 2 study is evaluating radiochemotherapy with a stereotactic boost for locally advanced non-small cell lung cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Centre Antoine Lacassagne | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: RECRUITING